- Home
- SPRY vs OPK Comparison
SPRY vs OPK Comparison
Compare SPRY & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPRY | OPK |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 946.0M | 1.0B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | SPRY | OPK |
|---|---|---|
| Price | $9.86 | $1.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $31.25 | $2.28 |
| AVG Volume (30 Days) | 2.0M | ★ 3.2M |
| Earning Date | 11-10-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $142,772,000.00 | ★ $642,067,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $124.59 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5459.66 | N/A |
| 52 Week Low | $6.66 | $1.11 |
| 52 Week High | $18.90 | $2.04 |
Technical Indicators
Market Signals| Indicator | SPRY | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 52.01 | 42.95 |
| Support Level | $10.02 | $1.30 |
| Resistance Level | $10.71 | $1.42 |
| Average True Range (ATR) | 0.63 | 0.05 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 34.36 | 21.57 |
Price Performance
Historical ComparisonAbout SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.